Skip to content

How It Works Pricing Blog Events Partners

Sign In Get Started →

How It Works Pricing Blog Events Partners

Sign In Get Started →

Loading people...

The OS for early-stage founders from day zero to raise.

Product

How It Works Pricing Partners

Resources

Blog Events Contact

Company

About Privacy Terms

© 2026 Startup Intros, Inc.San Francisco, CA · Made for Founders

Home
/People
/Theresa M. Reineke

§ Investor Profile

Theresa M. Reineke

Updated:Apr 2, 2026

About Experience Investments FAQs

Quick Facts

Role: Editor in Chief Bioconjugate Chemistry
Company: ACS
Status: Active
Type: Investor

Subscribe, Save or Share

Join 25K+ founders & VCs who start their week informed.

Experience

Editor in Chief Bioconjugate ChemistryCurrent

Present - Present

Frequently Asked Questions

Who is Theresa M. Reineke?

Theresa M. Reineke is Editor in Chief Bioconjugate Chemistry at ACS.